Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Combinations in Recurrent Glioblastoma
NCT00335764Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2006
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by National Cancer Institute. Started Apr 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00335764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335764.